|
Ranibizumab
|
雷尼株单抗
|
347396-82-1
|
|
IFN-γ
|
人白细胞干扰素
|
284690-33-1
|
|
antibody
|
抗体
|
|
|
Atezolizumab
|
阿特珠单抗
|
1380723-44-3
|
|
Pembrolizumab
|
派姆单抗
|
1374853-91-4
|
|
Trastuzumab
|
曲妥珠单抗
|
|
|
Ustekinumab
|
乌司奴单抗
|
815610-63-0
|
|
Cetuximab
|
西妥昔单抗
|
205923-56-4
|
|
EPO
|
红细胞生成素
|
11096-26-7
|
|
Nivolumab
|
纳武单抗
|
946414-94-4
|
|
Insulin
|
猪胰岛素
|
12584-58-6
|
|
Alemtuzumab
|
阿伦单抗
|
216503-57-0
|
|
Bevacizumab
|
贝伐珠单抗
|
216974-75-3
|
|
Obinutuzumab
|
|
|
|
Alirocumab
|
阿利库单抗
|
1245916-14-6
|
|
Avelumab
|
阿维鲁单抗
|
1537032-82-8
|
|
Pertuzumab
|
帕妥珠单抗
|
380610-27-5
|
|
Adalimumab
|
阿达木单抗
|
331731-18-1
|
|
pd-L1
|
Anti-PDZ and LIM domain protein 1
|
|
|
TRYPSIN FROM BOVINE PANCREAS SEQUENCING
|
胰岛素
|
|